GEODE CAPITAL MANAGEMENT, LLC - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,881,160
-36.8%
2,642,915
+12.5%
0.00%
-100.0%
Q2 2023$4,559,407
+372.7%
2,350,210
+112.0%
0.00%
Q1 2023$964,555
+165346.8%
1,108,684
+88.7%
0.00%
Q4 2022$583
-99.9%
587,516
+19.0%
0.00%
Q3 2022$844,000
+363.7%
493,657
+160.4%
0.00%
Q2 2022$182,000
-43.1%
189,548
+3.4%
0.00%
Q1 2022$320,000
-21.4%
183,277
+2.9%
0.00%
Q4 2021$407,000
-56.7%
178,0600.0%0.00%
Q3 2021$941,000
-10.6%
178,060
+10.0%
0.00%
Q2 2021$1,052,000
-52.7%
161,917
-37.3%
0.00%
Q1 2021$2,222,000
+34.8%
258,165
+0.7%
0.00%
Q4 2020$1,648,000
+0.2%
256,454
+5.5%
0.00%
Q3 2020$1,645,000
-22.6%
242,988
+6.6%
0.00%
Q2 2020$2,124,000
+1.4%
227,972
+8.9%
0.00%
-100.0%
Q1 2020$2,094,000
-45.9%
209,419
-42.1%
0.00%
Q4 2019$3,870,000
+166.0%
361,842
+215.9%
0.00%
Q3 2019$1,455,000
-15.0%
114,532
+0.4%
0.00%
Q2 2019$1,711,000
+663.8%
114,081
+784.2%
0.00%
Q1 2019$224,00012,9020.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 6,247,500$6,809,7752.18%
Bain Capital Life Sciences Investors, LLC 15,960,588$17,397,0411.94%
Stonepine Capital Management, LLC 5,273,685$5,748,3171.91%
NEA Management Company, LLC 14,986,793$16,335,6041.26%
Sio Capital Management, LLC 2,599,003$2,832,9130.88%
New Leaf Venture Partners, L.L.C. 335,000$365,1500.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$2,151,3140.25%
Monashee Investment Management LLC 427,265$465,7190.20%
Orbimed Advisors 7,133,515$7,775,5310.16%
Parkman Healthcare Partners LLC 800,000$872,0000.16%
View complete list of X4 PHARMACEUTICALS INC shareholders